Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Roku, GGP, and Nektar Therapeutics Jumped Today


Why Roku, GGP, and Nektar Therapeutics Jumped Today

The stock market got off to a solid start on Monday, bouncing back from small losses early in the trading day to finish with modest gains. Major benchmarks were up less than a quarter percent as market participants kept their eyes on the slowing trickle of third-quarter earnings reports as well as the negotiations related to tax reform in Washington. Some individual stocks logged significant gains. Roku (NASDAQ: ROKU), GGP (NYSE: GGP), and Nektar Therapeutics (NASDAQ: NKTR) were among the best performers on the day. Below, we'll look more closely at these stocks to tell you why they did so well.

Shares of Roku continued their upward surge from last week, surging nearly 30% to post the stock's third big daily gain in a row as excitement keeps building about the streaming media player manufacturer's prospects. Strong earnings results from Roku ignited the upward move for the stock late last week, and those following the company have marveled at the pace at which CEO Anthony Wood has joined the ranks of technology billionaires. If Roku continues to gain adoption among manufacturers of televisions and other hardware and can keep its advertisers happy, then there's every reason to think that the company can support a healthy share-price valuation.

Image source: Roku.

Continue reading


Source: Fool.com

Nektar Therapeutics Stock

€1.04
-1.320%
We can see a decrease in the price for Nektar Therapeutics. Compared to yesterday it has lost -€0.014 (-1.320%).
Currently there is a rather positive sentiment for Nektar Therapeutics with 3 Buy predictions and 1 Sell predictions.
With a target price of 3 € there is potential for a 187.63% increase which would mean more than doubling the current price of 1.04 € for Nektar Therapeutics.
Like: 0
Share

Comments